Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526331 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
A Phase 4 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
NCT00526331: Completed Phase 4 study, sponsored by M.D. Anderson Cancer Center.
NCT00526331 is a Phase 4 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00526331, a Phase 4 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the early identification and more precise intervention of operating room (OR) patient fluid administration optimization using arterial pressure-based cardiac output (APCO) yields comparable patient outcome as fluid administration optimization using a global standard care method.
Interventions
- DEVICE Vigileo Monitor
- DEVICE FloTrac Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00526331
The ClinicalTrials.gov registry entry for NCT00526331 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vigileo Monitor is the first listed.
NCT00526331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00526331 about?
NCT00526331 is a clinical study titled "Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy". The purpose of this study is to determine whether the early identification and more precise intervention of operating room (OR) patient fluid administration optimization using arterial pressure-based cardiac output (APCO) yields comparable patient outcome as fluid administration optimization using a...
What is the current status of trial NCT00526331?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2007-08. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00526331?
The interventions under investigation include: Vigileo Monitor (DEVICE), FloTrac Sensor (DEVICE).
Who is sponsoring clinical trial NCT00526331?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.